Novel technology and the development of pharmacogenetics within the pharmaceutical industry

By Gibson Neil   Jawaid Ansar   March Ruth  

Pharmacogenomics, Vol. 6, Iss. 4, 2005-06 ,pp. : 339-356

Future Medicine

Access to resources Recommend Favorite

A chance to improve pharmacovigilance

By  

Reactions Weekly, Vol. 1, Iss. 1218, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Public Perceptions of the Pharmaceutical Industry and Drug Safety: Implications for the Pharmacovigilance Professional and the Culture of Safety

By Olsen Axel K.  

Drug Safety, Vol. 32, Iss. 10, 2009-10 ,pp. : 805-810

Adis International

Access to resources Recommend Favorite

Standardization of pharmacovigilance definitions will improve the clarity of healthcare communication

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 5, 2008-05 ,pp. : 25-26

Adis International

Access to resources Recommend Favorite

Pharmacovigilance during the Pre-Approval Phases: An Evolving Pharmaceutical Industry Model In Response To ICH E2E, CIOMS VI, FDA and EMEA/CHMP Risk-Management Guidelines

By Hartford Craig G.  

Drug Safety, Vol. 29, Iss. 8, 2006-01 ,pp. : 657-673

Adis International

Access to resources Recommend Favorite